histamine has been researched along with ono-ae1-329 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayaishi, O; Huang, ZL; Mochizuki, T; Okada, T; Qu, WM; Sato, Y; Urade, Y; Yamatodani, A | 1 |
Aihara, E; Kato, S; Takeuchi, K; Yoshii, K | 1 |
Benyahia, C; Boukais, K; Danel, C; Gomez, I; Kanyinda, L; Leséche, G; Longrois, D; Norel, X | 1 |
3 other study(ies) available for histamine and ono-ae1-329
Article | Year |
---|---|
Prostaglandin E2 activates the histaminergic system via the EP4 receptor to induce wakefulness in rats.
Topics: Animals; Dinoprostone; Dose-Response Relationship, Drug; Frontal Lobe; Histamine; Histidine Decarboxylase; Hypothalamic Area, Lateral; Hypothalamus; Male; Methyl Ethers; Microdialysis; Neurons; Perfusion; Preoptic Area; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; RNA, Messenger; Wakefulness | 2003 |
Dual action of prostaglandin E2 on gastric acid secretion through different EP-receptor subtypes in the rat.
Topics: Animals; Dinoprostone; Drug Interactions; Enterochromaffin Cells; Gastric Acid; Histamine; Histamine Release; Male; Methyl Ethers; Parietal Cells, Gastric; Pentagastrin; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Vagotomy | 2005 |
PGE(2) receptor (EP(4)) agonists: potent dilators of human bronchi and future asthma therapy?
Topics: Acetylcholine; Aged; Animals; Asthma; Bronchi; Bronchodilator Agents; Data Interpretation, Statistical; Dinoprostone; Dose-Response Relationship, Drug; Female; Histamine; Humans; Immunoglobulin E; In Vitro Techniques; Male; Methyl Ethers; Mice; Mice, Inbred C57BL; Middle Aged; Papaverine; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Trachea; Vasodilator Agents | 2012 |